Insulet Corporation

NASDAQ:PODD

Medical - Devices

Healthcare
$139.98 -2.82%

-$4.17 today

Market cap
$9.71B
Beta
1.13
P/E (TTM)
33.2
EPS (TTM)
$4.33
52W Low $140.63High $354.88

Volume 2.09M

Average 1.32M

PODD Operating Income

Profit from core operations after operating expenses, before interest and taxes.

Insulet CorporationNASDAQ: PODD

Operating Income · Q2 FY2026 · quarter ended Jun 2026

Operating income grows, but more slowly than its trailing trend

Q2 FY2026 operating income of $129.7M rose 7.1% year over year, behind the +26.6% change in trailing-twelve-month operating income. Sequentially, it rose 6.2% from the prior quarter. Over 3 fiscal years it compounded at +132.7% a year.

Context

  • Operating income amounted to 17.5% of revenue in FY2025, up 2.6 pp from a year earlier.
  • Operating income increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether operating income reaches the consensus estimate from 19 analysts of $668.1M (+41.0%) for the fiscal year ending Dec 2026, a slowdown from the +53.4% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$129.7M+6.2% QoQ
Last fiscal yearDec 2025
$473.8M+53.4% YoY
LTMJun 2026
$515.8M+26.6% YoY
Operating Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+7.1%+28.0%+20.9 pp
1 year+53.4%+41.0%-12.4 pp
3-year CAGR+132.7%+21.5%-111.2 pp
5-year CAGR+19.7%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Income history

USD · from the income statement

Latest · FY2025
473.8M USD
Year-over-year change
+53.4%
4-year CAGR
+39.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Income vs competitors

How PODD compares with its peers on the latest reported figures

  • PODD's LTM Jun 2026 operating income of $515.8M is the 2nd highest of the 5 companies compared; the peer median is -$79.16M.
  • Its year-over-year change of +26.6% is the 3rd highest of 5, against a peer median of +15.4%.
  • Operating income amounts to 16.9% of revenue for PODD, versus a peer median of 46.5%.
PODD Competitors Peer median
Operating Income for PODD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DXCMDexCom, Inc.LTM Jun 2026$1.14B +65.8%+32.6%22.9%
PODDInsulet CorporationLTM Jun 2026$515.8M +26.6%+132.7%16.9%
BBNXBeta Bionics, Inc.LTM Mar 2026-$77.31M -42.0%—70.1%
TNDMTandem Diabetes Care, Inc.LTM Mar 2026-$81.01M +54.6%—7.9%
SENSSenseonics Holdings, Inc.LTM Mar 2026-$86.7M -23.7%—213.0%
Peer median (excluding PODD) -$79.16M+15.4%+32.6%46.5%

Competitors are the stored peer set for PODD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.1B1.31B1.7B2.07B2.71B
Cost of Revenue346.7M499.7M537.2M625.9M768.2M
Gross Profit752.1M805.6M1.16B1.45B1.94B
Gross Margin68.4%61.7%68.3%69.8%71.6%
Research & Development160.1M180.2M205M219.6M301.1M
Selling, General & Admin466M587.8M734.9M917.2M1.17B
Operating Expenses626.1M768M939.9M1.14B1.47B
Depreciation & Amortization57.4M63.2M72.8M80.8M90.4M
EBITDA139.6M109M323.6M423.7M509.6M
EBITDA Margin12.7%8.4%19.1%20.5%18.8%
Operating Income126M37.6M220M308.9M473.8M
Operating Margin11.5%2.9%13.0%14.9%17.5%
Interest Income500K9.3M28.6M39.5M34.7M
Interest Expense61.7M36M36.2M42.7M79.7M
Other Income / Expenses(105.5M)(27.8M)(5.4M)(8.7M)(134.3M)
Income Before Tax20.5M9.8M214.6M300.2M339.5M
Pre-Tax Margin1.9%0.8%12.6%14.5%12.5%
Income Tax Expense3.7M5.2M8.3M(118.1M)92.4M
Net Income16.8M4.6M206.3M418.3M247.1M
Net Margin1.5%0.4%12.2%20.2%9.1%
EPS (Basic)0.250.072.965.973.51
EPS (Diluted)0.250.072.945.783.48
Weighted Avg Shares67.7M69.38M69.75M70.08M70.35M
Weighted Avg Shares (Diluted)68.58M69.91M73.63M73.89M71.89M

Insulet Corporation

NASDAQ:PODD

Intrinsic Alpha fair value

Locked

Current Price

$139.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.